VC firm
Vivo Capital
Also known as Vivo Capital LLC, Vivo Innovation Fund, Vivo Opportunity Fund, Vivo Panda, Vivo Panda Fund, L.P., Vivo Ventures VII Affiliates, Vivo Ventures VII Affiliates Fund, L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-28Source (opens in a new tab)
- Headquarters
- Palo Alto, California, United States
- Founded
- 1996
- Assets under management
- $6.1BStated by firm, as of 2026-09-17Source (opens in a new tab)
- Funds
- 16
- Legal name
- Vivo Capital, LLC
Record updated 29 September 2026
About
Vivo Capital is a global healthcare-focused investment platform running multi-strategy capital across venture capital, private equity and public equity. Its venture strategy (Vivo Innovation Fund) backs venture-stage healthcare technology and product companies; its private equity strategy provides growth capital and pursues buyouts of companies with attractive growth prospects; its public equity strategy (Vivo Opportunity Fund) invests long-only in small and mid-cap biotech, pharma, healthcare and life-science public companies. The firm has invested in more than 460 healthcare companies globally since being SEC-registered in 2014, and is headquartered in Palo Alto, California with offices across Asia.
Investment approach
- Thesis
- Providing financing and resources from the Vivo Ecosystem to catalyze innovation and growth in the global healthcare markets.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Mr. Fu serves on the boards of a number of public and private healthcare companies.
- Investing status notes
- Home page "Latest News" lists recent 2025/2026 activity: "Vivo Capital Appoints Neetesh Kumar as Managing Partner to Co-Lead Private Equity Strategy in the U.S.", "Full-Life Technologies Announces US$150Million Financing Led by Vivo Capital", and a 30th-anniversary announcement, indicating ongoing active investing.
Funds
- Vivo Panda Fund, L.P.
- $100MVintage 2016, Main fund, SEC amount sold
- Vivo Ventures VII Affiliates Fund, L.P.
- $6.4MVintage 2011, Main fund, SEC amount sold
- VIVO VENTURES FUND VII, LP
- Main fund
- VIVO SUPER VIII LIMITED
- Main fund
- VIVO CAPITAL FUND IX, L.P.
- Main fund
- VIVO OPPORTUNITY FUND HOLDINGS, L.P.
- Opportunity
- VIVO CAPITAL SURPLUS FUND VIII, L.P.
- Main fund
- VIVO CO-INVEST (C), L.P.
- SPV
- VIVO VENTURES FUND CAYMAN VII, LP
- Main fund
- VIVO ARRACE FUND, L.P.
- Main fund
- VIVO OPPORTUNITY CO-INVEST, L.P.
- SPV
- VIVO ASIA OPPORTUNITY FUND HOLDINGS, L.P.
- Opportunity
- More funds
- 4 more recorded
SEC registration
- Registered adviser
- VIVO CAPITAL LLC
- CRD number
- 159868 (opens in a new tab)
- SEC file number
- 801-79829
- Registration
- SEC registered
- Regulatory AUM
- $6.1Bas of 2026-03-31
- Private funds reported
- 16
- Principal office
- PALO ALTO, CA, United States
- SEC CIK
- 1538309, 1675490
Locations
- Headquarters
- Palo Alto, CA, United States
- Office
- Beijing, China
- Office
- Shanghai, China
- Office
- Hong Kong, Hong Kong
- Office
- Singapore, Singapore
- Office
- Taipei, Taiwan